21Apr, 2022

Leveraging HJB’s highly productive continuous perfusion platform, client’s manufacturing process output was increased by > 8 folds and the process change was recently approved by NMPA.

EXPAND CLOSE OPEN IN NEW PAGE

31Mar, 2022

HJB Congratulates its partner BioneCure for receiving IND approval from U.S.FDA for BIO-106

HJB congratulates its partner BioneCure for receiving IND approval for BIO-106.

EXPAND CLOSE OPEN IN NEW PAGE

30Dec, 2021

HJB congratulates its client on an approval of CMC process change supplemental application filed to Chinese National Medical Products Administration (NMPA) in support of a late phase clinical trial in China.

HJB congratulates its client on an approval of CMC process change supplemental application filed to NMPA in support of a late phase clinical trial in China.

EXPAND CLOSE OPEN IN NEW PAGE

21Aug, 2021

HJB Congratulates Kanova Biopharma on receiving IND approval for XKH001 from U.S.FDA

HJB Congratulates its partner Kanova Biopharma for receiving IND approval from U.S.FDA for XKH001, a humanized monoclonal antibody for the treatment of autoimmune disease.

EXPAND CLOSE OPEN IN NEW PAGE

06Jul, 2021

HJB Congratulates its partner for receiving IND approval from NMPA

HJB congratulates its partner for receiving IND approval from NMPA.

EXPAND CLOSE OPEN IN NEW PAGE

05Jul, 2021

HJB Congratulates Miracogen for receiving IND acceptance for MRG004A from NMPA

HJB Congratulates its partner Miracogen for receiving IND acceptance from NMPA for MRG004A, an tissue factor-targeted antibody–drug conjugate.

EXPAND CLOSE OPEN IN NEW PAGE

01Jun, 2021

HJB's Automated Drug Product Vial Filling Line Is Ready for Clinical Projects

HJB has installed, commissioned, and validated a new Bosch fully isolated and automated drug product vial filling line and is ready for clinical projects.

EXPAND CLOSE OPEN IN NEW PAGE

13Apr, 2021

HJB Congratulates its partner for receiving IND approval from U.S.FDA

HJB congratulates its partner for receiving IND approval from FDA.

EXPAND CLOSE OPEN IN NEW PAGE